Investors’ deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approvals and M&A.

A fresh wave of layoffs jolted the Bay Area during March with several rounds of cutbacks that erased well over 600 jobs.

Under the new collaboration, OpenFold will produce a fine-tuned version of its model that’s trained on AbbVie and Johnson & ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Shares of Portage Biotech Inc. more than doubled in after-hours trading on Thursday as the company reported promising ...

Australian money managers Regal Partners Ltd. and Pengana Capital Group Ltd. are facing increased scrutiny from investors ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Insiders have been showing their love for these four biotech stocks, and one tech stock, lately with huge share purchases.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

Portage Biotech (PRTG) presented new preclinical data for PORT-7, a selective Adenosine A2B receptor inhibitor. The new data demonstrate both ...

Acknowledging the crucial role of start-ups in propelling India's biotech sector, Dr. Singh called for stronger handholding ...